AB SCIEX Expands in Singapore
News Nov 01, 2013
The facility is an extension of the company's $10-million global operations in Marsiling where life science industry-leading analytical instruments, including the AB SCIEX 6500 series and TripleTOF®series, are manufactured.
The AB SCIEX R&D Centre is focused on product development and brings R&D and manufacturing closer together. As a global leader in scientific technologies for biological and chemical analysis, AB SCIEX spends close to 10 percent of its annual revenues on R&D, which is a driving force for the company's continued innovation in LC/MS/MS (liquid chromatography/tandem mass spectrometry).
The company has also invested in an application support and training facility in the Biopolis, which is Singapore's state-of-the-art biomedical research hub housing a community of public and private researchers.
"Our significant investments in research and development, manufacturing and personnel reaffirm our commitment to Singapore as a hub for AB SCIEX global operations," said Rainer Blair, President of AB SCIEX. "As a trusted partner with scientists all over the world, we will continue to drive new innovation and push the limits of analytical science."
AB SCIEX joins more than 50 biotechnology and life science companies that have an R&D presence in Singapore.
"We are excited about the opening of AB SCIEX's R&D Centre in Singapore ‒ its first R&D centre outside North America. The centre will design and develop new instruments from Singapore for global markets. This is an excellent example of how leading life science tools companies such as AB SCIEX are looking to Singapore as an integrated home in Asia for complex instrument manufacturing, headquarter functions as well as R&D to support their future growth," said Ms Thien Kwee Eng, Assistant Managing Director, Singapore Economic Development Board.
The company's expansion in Singapore positions AB SCIEX to better serve its customers across Asia-Pacific.
"Our proximity to Asia-Pacific customers creates greater opportunities for regional input into new products that can transform health and safety," said KY Wong, Vice President of Global Operations at AB SCIEX. "Also, by being in Singapore, we have strategic access to the Asian market's supply chain resources."
On the production side, AB SCIEX has completed the transfer of manufacturing Eksigent chromatography products from the United States to Singapore. The physical expansion of manufacturing in its Marsiling factory in northern Singapore is part of a progressive plan for the Southeast Asian manufacturing operation to take on an increased number of products.
Fossilized Algae Hold Promise for Improved Food Safety TestingNews
Researchers, exploiting thin-layer chromatography and surface-enhanced Raman scattering, have used fossilized remains of algae to take a key step toward being able to more sensitively detect harmful contaminants in food.READ MORE
Rapid Removal of Arsenic From Drinking Water...By Moss!News
A moss capable of removing arsenic from contaminated water has been discovered by researchers. And it happens quickly – in just one hour, the arsenic level is so low that the water is no longer harmful for people to drink.READ MORE
Stable Beta-Amyloid Dimers Identified in Alzheimer’s BrainsNews
A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.
Comments | 0 ADD COMMENT
International Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018